144 related articles for article (PubMed ID: 21377305)
21. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion.
Nishie A; Stolpen AH; Obuchi M; Kuehn DM; Dagit A; Andresen K
J Magn Reson Imaging; 2008 Sep; 28(3):705-13. PubMed ID: 18777555
[TBL] [Abstract][Full Text] [Related]
22. Role of diffusion-weighted magnetic resonance imaging in the diagnosis of gallbladder cancer.
Kim SJ; Lee JM; Kim H; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Jul; 38(1):127-37. PubMed ID: 23281048
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of focal liver lesions with gadoxetic acid-enhanced MRI: is a shortened delay time possible by adding diffusion-weighted imaging?
Kim MY; Kim YK; Park HJ; Park MJ; Lee WJ; Choi D
J Magn Reson Imaging; 2014 Jan; 39(1):31-41. PubMed ID: 24115329
[TBL] [Abstract][Full Text] [Related]
24. Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods.
Holzapfel K; Eiber MJ; Fingerle AA; Bruegel M; Rummeny EJ; Gaa J
Abdom Imaging; 2012 Feb; 37(1):74-82. PubMed ID: 21597893
[TBL] [Abstract][Full Text] [Related]
25. Detection and classification of focal liver lesions in patients with colorectal cancer: retrospective comparison of diffusion-weighted MR imaging and multi-slice CT.
Eiber M; Fingerle AA; Brügel M; Gaa J; Rummeny EJ; Holzapfel K
Eur J Radiol; 2012 Apr; 81(4):683-91. PubMed ID: 21316886
[TBL] [Abstract][Full Text] [Related]
26. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
Park HJ; Kim SH; Jang KM; Lim S; Kang TW; Park HC; Choi D
AJR Am J Roentgenol; 2014 Jan; 202(1):92-101. PubMed ID: 24370133
[TBL] [Abstract][Full Text] [Related]
27. Additional diffusion-weighted imaging in the detection of new, very small hepatocellular carcinoma lesions after interventional therapy compared with conventional 3 T MRI alone.
Qu JR; Li HL; Shao NN; Li X; Yan GL; Zhang HK; Luo JP; Zhang SN; Li YL; Liu CC
Clin Radiol; 2012 Jul; 67(7):669-74. PubMed ID: 22336669
[TBL] [Abstract][Full Text] [Related]
28. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
Yu JS; Kim JH; Chung JJ; Kim KW
J Magn Reson Imaging; 2009 Jul; 30(1):153-60. PubMed ID: 19557734
[TBL] [Abstract][Full Text] [Related]
29. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
30. Detection of liver metastasis: is diffusion-weighted imaging needed in Gd-EOB-DTPA-enhanced MR imaging for evaluation of colorectal liver metastases?
Tajima T; Akahane M; Takao H; Akai H; Kiryu S; Imamura H; Watanabe Y; Kokudo N; Ohtomo K
Jpn J Radiol; 2012 Oct; 30(8):648-58. PubMed ID: 22836904
[TBL] [Abstract][Full Text] [Related]
31. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI.
Wu LM; Chen XX; Xu JR; Zhang XF; Suo ST; Yao QY; Fan Y; Hu J
Acad Radiol; 2013 Aug; 20(8):939-46. PubMed ID: 23746384
[TBL] [Abstract][Full Text] [Related]
32. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI.
Low RN; Gurney J
J Magn Reson Imaging; 2007 Apr; 25(4):848-58. PubMed ID: 17335018
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
34. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.
Ren J; Huan Y; Li F; Wang H; Ge Y; Chang Y; Yin H; Sun L
J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of enhanced magnetic resonance and diffusion-weighted imaging for detection of hepatic metastases].
Qian HF; Zhu YM; Wu X; Li FQ; Xuan HB; Shen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):621-4. PubMed ID: 23286411
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of focal liver lesions suspected of metastases by diffusion-weighted imaging (DWI): systematic comparison favors free-breathing technique.
Baltzer PA; Schelhorn J; Benndorf M; Dietzel M; Kaiser WA
Clin Imaging; 2013; 37(1):97-103. PubMed ID: 23206614
[TBL] [Abstract][Full Text] [Related]
37. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer.
Yoshida S; Masuda H; Ishii C; Tanaka H; Fujii Y; Kawakami S; Kihara K
AJR Am J Roentgenol; 2011 Jan; 196(1):110-6. PubMed ID: 21178054
[TBL] [Abstract][Full Text] [Related]
39. A pooled analysis of diffusion-weighted imaging in the diagnosis of hepatocellular carcinoma in chronic liver diseases.
Wu LM; Xu JR; Lu Q; Hua J; Chen J; Hu J
J Gastroenterol Hepatol; 2013 Feb; 28(2):227-34. PubMed ID: 23190006
[TBL] [Abstract][Full Text] [Related]
40. Breast diffusion-weighted MRI: comparison of tetrahedral versus orthogonal diffusion sensitization for detection and localization of mass lesions.
Ueguchi T; Yamada S; Mihara N; Koyama Y; Sumikawa H; Tomiyama N
J Magn Reson Imaging; 2011 Jun; 33(6):1375-81. PubMed ID: 21591006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
